Triathlon Medical Ventures Triathlon Medical Ventures
Triathlon Medical Ventures Triathlon Medical Ventures Triathlon Medical Ventures
Triathlon Medical Ventures - Homepage
Triathlon Medical Ventures - Team
Triathlon Medical Ventures - Investment Focus
Triathlon Medical Ventures - Investment Strategy
Triathlon Medical Ventures - Investment Criteria
Contact Triathlon Medical Ventures - Evaluation Process
Triathlon Medical Ventures - Portfolio
Triathlon Medical Ventures - News
Triathlon Medical Ventures - Links
Contact Contact Triathlon Medical Ventures

Triathlon Medical Ventures

 

 

 

 

 

National Venture Capital Association 2008-2009 Member


Whether you're an entrepreneur or a venture capitalist, you'll find a warm welcome at Triathlon Medical Ventures. Prior to opening our doors in 2004, Triathlon's team has been investing in life science business opportunities for more than fifteen years. And we are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.

Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.

We are geographically focused on early stage opportunities in the Midwest but will also invest in later stage companies nationwide. We are headquartered in Cincinnati, with offices and partners in Indianapolis, Louisville and St. Louis. The partners are industry veterans with extensive experience as both operational managers and venture capitalists.

We invite you now to explore these web pages and consider how Triathlon Medical Ventures might be the right partner for your investment opportunity.



RECENT NEWS

October 31, 2008
Mitralign® Initiates it's First European Study


October 31, 2008
Symphony Drums Up $10M On Way To Series C


October 28, 2008
CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development


October 10, 2008
AcelleRX Therapeutics Raises $6.9 Million From Investors


September 3, 2008
Triathlon Medical Ventures Adds New Company to Portfolio — Expanding Orthopedics, Inc. Offers Broad Platform of Cutting-edge Technology


July 11, 2008
CoLucid Tries to Prove That a Virtual Biotech Can Produce Real Returns


July 1, 2008
CoLucid Pharmaceuticals Announces $25 Million Series B Financing

June 16, 2008
Tolera Therapeutics Closes Series A Financing, Raises $8 Million to Begin Antibody Manufacturing and Working With FDA on Clinical Trials


April 22, 2008
FDA Agrees to First SPA for an Oncolytic Product


February 8, 2008
Triathlon Invests in Cancer Firm



 
 
Copyright © 2004 - Triathlon Medical Ventures - All Rights Reserved Web Site Credits Legal Notices & Privacy Policy